To examine the distribution of SIN3A in tissues removed from patients with breast cancers, immunohistochemical observation was carried out using the antibody against the N-terminal peptide of SIN3A as an antigen to detect the WT and the mutant deleting C-terminal regions. Here, SIN3A is linked to breast carcinoma.